In conclusion, serum PDGF-BB levels decreased remarkably during fibrogenesis and these could be used as a non-invasive biomarker of fibrosis stage in patients with CHB. Furthermore, the PGT score showed equal efficiency to other fibrosis scores in diagnosing significant fibrosis in patients with normal ALT.